Flexion Therapeutics Inc

Flexion Therapeutics — Q3 2020 Earnings Presentation

7 slides from Flexion Therapeutics's earnings presentation, Oct 13, 2020

  1. Slide 1: Commercial Metrics Overview

    Commercial Metrics Overview October 13, 2020 Exhibit 99.2

  2. Slide 2: Commercial Metrics Overview

    Commercial Metrics Overview Preliminary ZILRETTA® net sales of ~$23.6 million in Q3 2020 4,072 accounts (of 5,400 targets) had purchased ZILRETTA, as of September 30, 2020; up from 3,858, as of June 30, 2020 3,153 accounts had re-ordered ZILRETTA (77% of accounts that had purchased), as of September

  3. Slide 3: ZILRETTA Net Sales

    ZILRETTA Net Sales Note: Flexion recognizes ZILRETTA sales upon receipt of product by specialty distributors and pharmacies. Quarterly since launch

  4. Slide 4: Distribution of Accounts by ZILRETTA Purchases

    Distribution of Accounts by ZILRETTA Purchases Note: Flexion primarily sells ZILRETTA to specialty distributors and a specialty pharmacy; accounts (physicians, clinics and certain medical centers or hospitals) then subsequently purchase ZILRETTA directly from these specialty distributors and special

  5. Slide 5: Distribution of ZILRETTA Purchases by Accounts

    Distribution of ZILRETTA Purchases by Accounts Cumulative

  6. Slide 6: ZILRETTA Purchases by New and Existing Accounts

    ZILRETTA Purchases by New and Existing Accounts Cumulative

  7. Slide 7: Transformative Medicine... Where It Matters

    clevion Transformative Medicine... Where It Matters

Flexion Therapeutics — Q3 2020 Earnings Presentation on 6ix